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Introduction
Atherosclerosis is an inflammatory disease characterized by intense immunological activity, which increasingly threatens human health worldwide [1] . With primary risk factors such as smoking, hypertension, hyperlipidaemia and hyperglycaemia, the incidence of atherosclerosis-related diseases is expected to further increase. The pathophysiology of atherosclerosis involves plaque formation in arteries characterized by inflammation, lipid accumulation, cell death and fibrosis [2, 3] [2] . Monocytes [80, 81] and transendothelial migration [82] . Increased adhesion may be due to enhanced ␤2-integrin mobilization from intracellular stores [81] 
Development of atherosclerotic plaques
Atherosclerosis is initiated by activation and dysfunction of endothelial cells subsequently leading to adhesion of leucocytes and activated platelets as well as increased permeability for plasma lipids
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Mast cells
In human beings, mast cells are derived from CD34
Ϫ progenitor cells [88] [89] [90] . [93] . [94] . [98] . [99] , the numbers of DCs were found to be increased in advanced human plaques [100, 101] [106] . Contrasting these observations, it has recently been shown that DC from mice fed high fat diet maintain antigen processing and antigen presentation capabilities as well as T-cell priming efficacy [107] . These conflicting data may result from differences in models applied and the focus on different DC subsets. Hence, this calls for further investigations on the effect of hyperlipidaemia on DC subsets in man and mouse. [108] , which is likely due to inhibited adhesion and transmigration of DC [109] . In addition, statins were shown to reduce DC maturation and subsequent T-cell stimulation [110] providing an alternative explanation for the beneficial effects of statins in atherosclerosis. [113] [114] [115] . Although some groups have previously highlighted CD133 as an EPC specific marker [116, 117] [119] [120] [121] [122] . Particularly, the Tie2-expressing monocytes have been intensively studied as key regulators in tumour angiogenesis [123] . Another type of cells can be isolated from peripheral blood mononuclear cells by using adhesion on fibronectin and culture in medium with endothelial growth factors [124] . Such [112, 115, 126] . Notably, reduced numbers of EPCs has been shown to correlate with the Framingham risk factor score and to predict future cardiovascular events [127, 128] . Functional defect of EPCs has also been described in diabetic patients [129] . Similarly, dysfunction of EPCs was reported in obesity and hypercholesterolemia [130, 131] . Oxidized LDL has been shown to decrease EPC survival and tube-formation capacity [132] , while HDL induced nitric oxide production and improved the engraftment of EPCs [133, 134] 
Much of this activity was dependent on mast cell degranulation and further research identified chymase and CXCR2 ligands as active compounds. In another approach development of atherosclerosis was studied in mice lacking mast cells. These mice exhibited decreased lesion size, lipid deposition, T cell and macrophage numbers, cell proliferation and apoptosis, but increased collagen content and fibrous cap development
Adoptive transfer of wild-type mast cells, but not transfer of mast cells lacking IL-6 or IFN-␥, restored plaque formation, thus indicating that IL-6 and IFN-␥ are primary effectors of mast cells. Secondarily, these mediators induce expression and release of matrix-degrading proteases thus resulting in plaque formation and destabilization. The same group demonstrated just recently that mast cells actively participate in the formation of aortic aneurysms by release of IL-6 and IFN-␥, which induced apoptosis of smooth muscle cells and protease expression [95]. As for PMN, the cytoplasm of mast cells is filled with preformed granules, which are readily released after cell activation. The instant availability of these mediators may attribute an important role in the onset of atherosclerosis [92]. Recently it has been shown that oxLDL induces activation and degranulation of mast cells [96]. In addition, mast cells are involved in accumulation of LDL in the vascular wall by increasing transendothelial permeability [97]. By means of oxidative modification granule proteins of mast cells contribute to the retention of LDL in the sub-endothelial space, thus enhancing foam cell formation
Dendritic cells
Dendritic cells (DC) are a heterogeneous set of antigen presenting cells consisting of conventional DC, plasmocytoid DC as well as inflammatory DC. While DCs form a network in the arterial intima of young healthy individuals
processing as well as Tcell stimulation. LDL and modified lipoproteins, such as oxLDL, represent an antigen that could trigger such a mechanism resulting in IFN-␥ production from T cells. In agreement with a potential axis of oxLDL-DC-T-cell stimulation is the finding that oxLDL enhances expression of costimulatory molecules by DC with subsequent T-cell proliferation [103, 104]. However, this notion is controversial inasmuch as it has been suggested that hyperlipidaemia inhibits activation of DC. Therein, it was shown that hyperlipidaemia impaired DC migration to lymph nodes thus suppressing immunological priming [105]. Reduced migration resulted from inhibitory signals generated by platelet-activating factor or oxLDL that acts as a platelet-activating factor (PAF) mimetic. Therefore, hyperlipidaemia may sequester activated DC in the periphery where they can aggravate local inflammation. Additionally, it was shown that hyperlipidaemia inhibits Toll-like receptor-induced production of pro-inflammatory cytokines and up-regulation of costimulatory molecules by a subset of DCs [106]. Subsequent Th1 responses were found to be profoundly diminished. Further analysis has proven oxLDL to be the key active component in this, as it could directly uncouple TLR-mediated signalling on DCs and inhibit NF-B nuclear translocation
Plaques of atherosclerotic patients on statins contain lower numbers of DCs as compared to control patients
Endothelial progenitor cells
EPCs circulate in peripheral blood of human beings and mice (Table 2). These cells can be considered as the currently most intensively studied adult progenitor cell population with relevance to endothelial regeneration and neovascularisation of ischemic tissue [111-113]. Besides some heterogeneity in origin and characterization, EPCs in human peripheral blood have most commonly been defined as low granular cells positive for CD34 and for the vascular endothelial growth factor receptor-2 (VEGFR2), but negative for the common leucocyte antigen CD45
